734 related articles for article (PubMed ID: 30121253)
21. Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study.
Quintero E; Carrillo M; Leoz ML; Cubiella J; Gargallo C; Lanas A; Bujanda L; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Morillas JD; Balaguer F; Muriel A;
PLoS Med; 2016 May; 13(5):e1002008. PubMed ID: 27138769
[TBL] [Abstract][Full Text] [Related]
22. Development of new non-invasive tests for colorectal cancer screening: the relevance of information on adenoma detection.
Haug U; Knudsen AB; Lansdorp-Vogelaar I; Kuntz KM
Int J Cancer; 2015 Jun; 136(12):2864-74. PubMed ID: 25403937
[TBL] [Abstract][Full Text] [Related]
23. Prospective colonoscopic study to investigate risk of colorectal neoplasms in first-degree relatives of patients with non-advanced adenomas.
Ng SC; Kyaw MH; Suen BY; Tse YK; Wong MCS; Hui AJ; Tak HY; Lau JYW; Sung JJY; Chan FKL
Gut; 2020 Feb; 69(2):304-310. PubMed ID: 31028155
[TBL] [Abstract][Full Text] [Related]
24. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
Quintero E
Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
[TBL] [Abstract][Full Text] [Related]
25. Screening patterns in patients with a family history of colorectal cancer often do not adhere to national guidelines.
Lin OS; Gluck M; Nguyen M; Koch J; Kozarek RA
Dig Dis Sci; 2013 Jul; 58(7):1841-8. PubMed ID: 23371014
[TBL] [Abstract][Full Text] [Related]
26. Effects of Family History on Relative and Absolute Risks for Colorectal Cancer: A Systematic Review and Meta-Analysis.
Roos VH; Mangas-Sanjuan C; Rodriguez-Girondo M; Medina-Prado L; Steyerberg EW; Bossuyt PMM; Dekker E; Jover R; van Leerdam ME
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2657-2667.e9. PubMed ID: 31525516
[TBL] [Abstract][Full Text] [Related]
27. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.
Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Hernández-Guerra M; Parra-Blanco A; Jiménez-Sosa A
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1062-7. PubMed ID: 19307978
[TBL] [Abstract][Full Text] [Related]
28. Appropriateness of colonoscopy in Europe (EPAGE II). Screening for colorectal cancer.
Arditi C; Peytremann-Bridevaux I; Burnand B; Eckardt VF; Bytzer P; Agréus L; Dubois RW; Vader JP; Froehlich F; Pittet V; Schusselé Filliettaz S; Juillerat P; Gonvers JJ;
Endoscopy; 2009 Mar; 41(3):200-8. PubMed ID: 19280531
[TBL] [Abstract][Full Text] [Related]
29. Study protocol of the RaPS study: novel risk adapted prevention strategies for people with a family history of colorectal cancer.
Tikk K; Weigl K; Hoffmeister M; Igel S; Schwab M; Hampe J; Klug SJ; Mansmann U; Kolligs F; Brenner H
BMC Cancer; 2018 Jul; 18(1):720. PubMed ID: 29976178
[TBL] [Abstract][Full Text] [Related]
30. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening.
Sung JJ; Ng SC; Chan FK; Chiu HM; Kim HS; Matsuda T; Ng SS; Lau JY; Zheng S; Adler S; Reddy N; Yeoh KG; Tsoi KK; Ching JY; Kuipers EJ; Rabeneck L; Young GP; Steele RJ; Lieberman D; Goh KL;
Gut; 2015 Jan; 64(1):121-32. PubMed ID: 24647008
[TBL] [Abstract][Full Text] [Related]
31. A population-based cross-sectional study of colorectal cancer screening practices of first-degree relatives of colorectal cancer patients.
Courtney RJ; Paul CL; Carey ML; Sanson-Fisher RW; Macrae FA; D'Este C; Hill D; Barker D; Simmons J
BMC Cancer; 2013 Jan; 13():13. PubMed ID: 23305355
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic accuracy of faecal immunochemical test for screening individuals with a family history of colorectal cancer.
Ng SC; Ching JY; Chan V; Wong MC; Suen BY; Hirai HW; Lam TY; Lau JY; Ng SS; Wu JC; Chan FK; Sung JJ
Aliment Pharmacol Ther; 2013 Oct; 38(7):835-41. PubMed ID: 23957462
[TBL] [Abstract][Full Text] [Related]
33. Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.
Robertson DJ; Lee JK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Lieberman D; Levin TR; Rex DK
Am J Gastroenterol; 2017 Jan; 112(1):37-53. PubMed ID: 27753435
[TBL] [Abstract][Full Text] [Related]
34. Fecal immunochemical test accuracy in familial risk colorectal cancer screening.
Castro I; Cubiella J; Rivera C; González-Mao C; Vega P; Soto S; Hernandez V; Iglesias F; Teresa Alves M; Bujanda L; Fernández-Seara J
Int J Cancer; 2014 Jan; 134(2):367-75. PubMed ID: 23818169
[TBL] [Abstract][Full Text] [Related]
35. Family history of colorectal cancer and prevalence of advanced colorectal neoplasia in asymptomatic screened populations in different age groups.
Sekiguchi M; Kakugawa Y; Nakamura K; Matsumoto M; Tomizawa Y; Murakami Y; Saito Y; Matsuda T
Gastrointest Endosc; 2020 Jun; 91(6):1361-1370. PubMed ID: 32004550
[TBL] [Abstract][Full Text] [Related]
36. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
[TBL] [Abstract][Full Text] [Related]
37. Association of Colonoscopy Adenoma Findings With Long-term Colorectal Cancer Incidence.
Click B; Pinsky PF; Hickey T; Doroudi M; Schoen RE
JAMA; 2018 May; 319(19):2021-2031. PubMed ID: 29800214
[TBL] [Abstract][Full Text] [Related]
38. Long-term risk of colorectal cancer after screen-detected adenoma: Experiences from a Danish gFOBT-positive screening cohort.
Bjerrum A; Lindebjerg J; Andersen O; Fischer A; Lynge E
Int J Cancer; 2020 Aug; 147(4):940-947. PubMed ID: 31894860
[TBL] [Abstract][Full Text] [Related]
39. A dedicated high-quality service for the management of patients with an inherited risk of colorectal cancer.
Adams LK; Qiu S; Hunt AK; Monahan KJ
Colorectal Dis; 2019 Aug; 21(8):879-885. PubMed ID: 30903731
[TBL] [Abstract][Full Text] [Related]
40. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
